Discover Treatment Options for Your Patients
Please select from the following topics in CPP
A Case Study for CPP Diagnosis and Treatment With a Twice-yearly GnRH Agonist
This case study walks through the process of diagnosing CPP in a 6.5-year-old female, and managing her CPP with a GnRH agonist.
For Your Patients With CPP, Consider Triptodur® (triptorelin)
Learn about a clinical trial and efficacy and safety for Triptodur, the #1 prescribed twice-yearly injectable GnRH agonist for CPP. You will also learn about the Triptodur CareSM program, created to help providers and patients with CPP every step of the way.
Dr. Yang is a paid consultant of Azurity Pharmaceuticals, Inc.
No CME credit is being offered as part of this program nor does it qualify for CME credit.